A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics
about
BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy.New Genetics and Genomic Data on Pancreatic Neuroendocrine Tumors: Implications for Diagnosis, Treatment, and Targeted Therapies.Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor developmentNETs: organ-related epigenetic derangements and potential clinical applications.Molecular subtypes in cancers of the gastrointestinal tract.The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform.A Novel Statistical Method to Diagnose, Quantify and Correct Batch Effects in Genomic Studies.Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.Genomic landscape of pancreatic neuroendocrine tumours: The International Cancer Genome Consortium.Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis.Whole-genome landscape of pancreatic neuroendocrine tumours.Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth.ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroupGenetic dissection of the miR-200-Zeb1 axis reveals its importance in tumor differentiation and invasion
P2860
Q27853371-A2541D2B-65FE-4953-957B-F8AB73D552FBQ36085145-39ED2DE2-0CDA-47F0-B014-DD00F24255DFQ36966614-5F2C903B-E29C-48E7-9B79-C4C4F9C9EAC1Q37346956-EFC15CA9-BFF9-4EA2-8BB3-8C4EBEFA2D1EQ38841735-6A8217BE-3D29-4349-9CCB-8897BD6C3E8AQ39235977-79F49BEB-4ACB-4110-AAF9-8297B8EF1A88Q41526718-E8C09C9E-9662-4A35-A739-9A12BEA11D2EQ41535701-B15615BF-0FDC-4FFA-8547-DEB22A6ECDFBQ41900072-52D3053B-086A-4303-8C79-F3767C8CE232Q47391475-596D162D-4C6B-41FA-BF7D-8068256BAFFAQ48520101-0DA4DBAE-BEED-4BB5-95F9-8204BC6A61DDQ50009957-21BAD310-C19C-4D4F-923C-90B7E438F3DAQ51137102-2D9F2631-5343-4CBA-B337-A27297B351F6Q55104265-B947C410-464E-4480-9891-E986C0CC7EE8Q55322458-3BFB4A8F-1AB4-4CC2-A0DB-46FD450AF07CQ57471936-A46E30C1-F1F2-4DD0-BAE3-86E1728732EAQ58599827-356D5B3F-937B-4BD2-8241-B3B00E1ABF96
P2860
A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 October 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A Cross-Species Analysis in Pa ...... and Metabolic Characteristics
@en
A Cross-Species Analysis in Pa ...... and Metabolic Characteristics.
@nl
type
label
A Cross-Species Analysis in Pa ...... and Metabolic Characteristics
@en
A Cross-Species Analysis in Pa ...... and Metabolic Characteristics.
@nl
prefLabel
A Cross-Species Analysis in Pa ...... and Metabolic Characteristics
@en
A Cross-Species Analysis in Pa ...... and Metabolic Characteristics.
@nl
P2093
P2860
P50
P1433
P1476
A Cross-Species Analysis in Pa ...... and Metabolic Characteristics
@en
P2093
Andrea Mafficini
Costas A Lyssiotis
Douglas Hanahan
Hendrik Bläker
Ismael Wafy
Jan Körner
John M Asara
Samantha Bersani
Stefano Barbi
Stephan Wullschleger
P2860
P304
P356
10.1158/2159-8290.CD-15-0068
P50
P577
2015-10-07T00:00:00Z